NAMPT inhibition functionally impairs key metabolic and signaling pathways in ALK + ALCL cells, notably including the enzymatic activity and oncogenic function of NPM1::ALK itself. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.